Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 7:43 pm Sale | 2025-06-12 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,075,952 9.980% | -187,850 (-14.86%) | Filing History |
| 2024-08-02 4:05 pm Sale | 2024-07-29 | 13D | Azitra, Inc. AZTR | Bios Equity Partners LP | 35,971 0.070% | -1,509,380 (-97.67%) | Filing History |
| 2024-03-01 4:10 pm Sale | 2024-02-28 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,263,802 11.800% | -202,889 (-13.83%) | Filing History |
| 2023-12-01 06:02 am Sale | 2023-11-29 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,466,691 13.600% | -508,150 (-25.73%) | Filing History |
| 2023-07-03 3:04 pm Purchase | 2023-06-21 | 13D | Azitra, Inc. AZTR | Bios Equity Partners LP | 1,545,351 56.900% | 1,545,351 (New Position) | Filing History |
| 2022-03-22 4:15 pm Purchase | 2022-03-17 | 13D | Lantern Pharma Inc. LTRN | Bios Equity Partners LP | 1,974,841 18.100% | 5,855 (+0.30%) | Filing History |